Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Profit After Tax (2016 - 2025)

BioCorRx's Profit After Tax history spans 16 years, with the latest figure at -$1.9 million for Q3 2025.

  • For Q3 2025, Profit After Tax fell 30.46% year-over-year to -$1.9 million; the TTM value through Sep 2025 reached -$959426.0, up 80.46%, while the annual FY2024 figure was -$5.2 million, 38.23% down from the prior year.
  • Profit After Tax for Q3 2025 was -$1.9 million at BioCorRx, down from $1.4 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $1.4 million in Q2 2025 and bottomed at -$1.9 million in Q3 2025.
  • The 5-year median for Profit After Tax is -$1.2 million (2022), against an average of -$960994.5.
  • The largest annual shift saw Profit After Tax crashed 73.62% in 2021 before it surged 211.61% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$1.2 million in 2021, then rose by 3.2% to -$1.2 million in 2022, then grew by 16.68% to -$969009.0 in 2023, then plummeted by 31.12% to -$1.3 million in 2024, then tumbled by 50.94% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Profit After Tax are -$1.9 million (Q3 2025), $1.4 million (Q2 2025), and $851764.0 (Q1 2025).